Capsida Company
Capsida is a biotechnology company that specializes in tackling monogenetic and sporadic CNS and non-CNS disorders.
Industry:
Early Drug Development
Headquarters:
Newbury Park, California, United States
Founded Date:
2019-01-01
Employees Number:
51-100
Investors Number:
3
Total Funding:
140000000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2023-02-23
Last Funding Type:
Corporate Round
Register and Claim Ownership